Lacidipine

In the article titled Lacidipine, a topic of great relevance today is addressed, which has generated a wide debate and has aroused the interest of society in general. Throughout this article, different aspects related to Lacidipine will be analyzed, from its origin to its impact on current society. Likewise, the different opinions and positions that exist around Lacidipine will be examined, in order to offer readers a complete and objective vision of the topic. In addition, relevant data, studies and research will be presented that will contribute to enriching knowledge about Lacidipine and deepening its understanding. Without a doubt, this article will be very useful for those interested in acquiring greater knowledge about Lacidipine and understanding its importance in today's society.

Lacidipine
Clinical data
Trade namesLacipil, Motens
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability~10%
Protein binding>95%
MetabolismHepatic
Onset of action30–50 min
Elimination half-life13–19 hours
ExcretionFeces (~70%)
Identifiers
  • Diethyl 4-{o-phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.166.373 Edit this at Wikidata
Chemical and physical data
FormulaC26H33NO6
Molar mass455.551 g·mol−1
3D model (JSmol)
  • CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C
  • InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+
  • Key:GKQPCPXONLDCMU-CCEZHUSRSA-N
  (verify)

Lacidipine (tradenames Lacipil or Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.

It was patented in 1984 and approved for medical use in 1991.

References

  1. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 466. ISBN 9783527607495.

External links


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia